The 20 Best Medulloblastoma Doctors Near Me in Bronx, NY

Nitin Ohri, MD, MS, is Professor, Radiation Oncology at Montefiore Einstein. He is a radiation oncologist with a clinical focus on treating lung and gastrointestinal cancers. Dr. Ohri is rated as an Advanced provider by MediFind in the treatment of Medulloblastoma. He is also highly rated in 48 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, and Nasopharyngeal Carcinoma.

Keyur Mehta is a Radiation Oncologist practicing medicine in Bronx, New York. Dr. Mehta is rated as an Advanced provider by MediFind in the treatment of Medulloblastoma. He is also highly rated in 42 other conditions, according to our data. His clinical expertise encompasses Cervical Cancer, Breast Cancer, Neuroendocrine Carcinoma of the Cervix, and Vulvar Cancer.

Rafi Kabarriti, MD, is a cum laude graduate of Columbia University with a bachelor’s degree in biochemistry and economics. Dr. Kabarriti is rated as an Advanced provider by MediFind in the treatment of Medulloblastoma. He is also highly rated in 54 other conditions, according to our data. His clinical expertise encompasses Anal Cancer, Laryngeal Cancer, Throat Cancer, Cervical Cancer, and Colonoscopy.

Jana Fox is a Radiation Oncologist practicing medicine in Bronx, New York. Dr. Fox is rated as an Advanced provider by MediFind in the treatment of Medulloblastoma. She is also highly rated in 38 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Angiosarcoma, Throat Cancer, and Laryngeal Cancer.

Justin Tang is a Radiation Oncologist practicing medicine in Bronx, New York. Dr. Tang is rated as an Advanced provider by MediFind in the treatment of Medulloblastoma. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Fibrolamellar Carcinoma, Prostate Cancer, Familial Prostate Cancer, and Cholangiocarcinoma (Bile Duct Cancer).

Adilia Hormigo, MD, PhD, is Leader, Neuro-Oncology Program, Co-Leader, Neuro-Oncology Multidisciplinary Disease Team and Professor, Hematology-Oncology, Neurosurgery, and Microbiology & Immunology at Montefiore Einstein. She is also a member of the Cancer Therapeutics Program. Her clinical expertise is the treatment of malignancies of the central nervous system and neurologic complications of cancer. Dr. Hormigo is rated as an Experienced provider by MediFind in the treatment of Medulloblastoma. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, Brain Tumor, and Myringotomy.

Katharine Mcneill is a Neurologist practicing medicine in Bronx, New York. Dr. Mcneill is rated as an Experienced provider by MediFind in the treatment of Medulloblastoma. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, and Brain Tumor.

Madhur Garg earned his medical degree at King George’s Medical College and completed his residency in radiation oncology at Rush-Presbyterian-St. Luke’s Hospital in Chicago and Montefiore in New York City. He also completed a specialized fellowship at Wayne State University in Detroit. Dr. Garg is rated as an Experienced provider by MediFind in the treatment of Medulloblastoma. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Cervical Cancer, Prostate Cancer, Acoustic Neuroma, and Familial Prostate Cancer.

Lisa Gennarini, MD, has been an Assistant Professor of Pediatrics in the Division of Pediatric Hematology/Oncology and Blood & Marrow Cell Transplantation at Children's Hospital at Montefiore (CHAM) since 2014. Her clinical focus is on treatment of children with leukemia and lymphoma as well as various vascular anomalies. She is also the CHAM Principal Investigator for Children?s Oncology Group trials, and also leads the CHAM Vascular Malformations Program. Dr. Gennarini graduated from Siena College in 2004, earning her Bachelor of Science in Biology. In 2008, she received her Doctor of Medicine at State University of New York, Upstate Medical University in Syracuse. She began a residency in Pediatrics at Jefferson Medical College/A.I. duPont Hospital for Children, followed by a fellowship in Pediatric Hematology/Oncology at Children?s Hospital at Montefiore. Dr. Gennarini's work on pediatrics, topics ranging from sickle cell disease to implementing communications skills training courses in pediatric hematology/oncology, has been published in various journals and books, and presented nationally. Dr. Gennarini is board certified by the American Board of Pediatrics in Pediatric Hematology/Oncology and General Pediatrics. Dr. Gennarini is rated as an Experienced provider by MediFind in the treatment of Medulloblastoma. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Leukemia, Neuroblastoma, Bone Marrow Aspiration, and Adenoidectomy.

David Loeb, MD, PhD, is Chief, Pediatric Hematology, Oncology and Cellular Therapy at Children’s Hospital at Montefiore and Professor, Pediatrics and Professor, Developmental and Molecular Biology at Montefiore Einstein. His clinical work focuses on tumors of connective tissue, such as bone and muscle. He also has expertise in the care of children with other solid tumors. As a member of the bone marrow transplantation team, Dr. Loeb also cares for patients with acute leukemias and has expertise in the application of immunotherapy to childhood cancer. Dr. Loeb is rated as an Experienced provider by MediFind in the treatment of Medulloblastoma. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Osteosarcoma, Ewing Sarcoma, Adult Soft Tissue Sarcoma, and Bone Tumor.

Adam Levy, MD, is a Clinical Professor who works per diem at Montefiore Einstein in the trainee’s clinic. He specializes in general pediatric hematology and oncology, with a focus on tumors of the brain and spine, solid tumors and tumors associated with neurofibromatosis. Dr. Levy is rated as an Experienced provider by MediFind in the treatment of Medulloblastoma. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Malignant Peripheral Nerve Sheath Tumor, Neurofibromatosis, Glioma, Spinal Fusion, and Laminectomy.

Allison M. Martin, MD, is an attending physician at the Children’s Hospital at Montefiore Einstein and Assistant Professor, Pediatrics, Microbiology and Immunology at our Albert Einstein College of Medicine. Dr. Martin’s clinical focus centers on pediatric brain and spinal cord tumors. Dr. Martin is rated as an Experienced provider by MediFind in the treatment of Medulloblastoma. Her clinical expertise encompasses Medulloblastoma, Neurofibromatosis Type 1 (NF1), and Immune Thrombocytopenic Purpura (ITP).

Dr. Sisti specializes in the treatment of complex brain tumors, meningiomas, and acoustic neuromas employing state of the art computer guided microneurosurgery and Gamma Knife radiosurgery. Dr. Sisti’s core belief is that by dedicating himself both to the best in medical technology and to the quality of the physician patient relationship, he provides the optimum opportunity for helping patients deal with these difficult brain tumors. He has safely and successfully operated upon more than seven thousand patients with these complex conditions. During his 30 year career in the Department of Neurosurgery at Columbia University’s world-class medical center Dr. Sisti has also pioneered many surgical and technical advances including New York City’s first non-invasive radiosurgery program. As a result of his personal philosophy and the long term concentrated experience in treating the most difficult tumors Dr. Sisti has earned a reputation for technical excellence in surgical results as well as providing superior personal care to his patients and their family members.Dr. Sisti is the James G. McMurtry III, MD Professor of Neurosurgery, Radiation Oncology & Otolaryngology. He is also the Co-director, Center for Radiosurgery. Watch Dr. Sisti's Videos:Meet Dr. Michael B. SistiMedical Minute: Metastatic Brain TumorsMedical Minute: Malignant Brain TumorsMedical Minute: MeningiomasMedical Minute: RadiosurgeryDr. Sisti shares his expertise on Acoustic NeuromasDr. Sisti's Patient Story. Dr. Sisti is rated as an Experienced provider by MediFind in the treatment of Medulloblastoma. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Glioblastoma, Meningioma, Glioma, Gamma Knife Radiosurgery, and Awake Craniotomy. Dr. Sisti is board certified in Neurological Surgery. Dr. Sisti is currently accepting new patients.

Andrew B. Lassman, MD, FAAN, FASCO, is a Professor of Neurology and Associate Dean of Clinical Research Compliance at the Columbia University Vagelos College of Physicians and Surgeons. Dr. Lassman also serves as Chief of the Division of Neuro-Oncology and Vice Chair for Clinical Research in the Department of Neurology, and as Associate Director for Clinical Trials at the Herbert Irving Comprehensive Cancer Center. As a clinician-scientist, Dr. Lassman focuses both his research and clinical efforts on improving the understanding and treatment of brain tumors.Dr. Lassman has particular expertise in translational clinical trials for brain tumors, with molecular correlative analyses to understand the reasons for treatment success or failure, and to refine treatment paradigms. Dr. Lassman has led retrospective studies, single institution prospective clinical trials, and multicenter prospective trials conducted nationally through the National Cancer Institute sponsored National Clinical Trials Network. His contributions to the field of Neuro-Oncology have been recognized with numerous awards, including the Preuss Award in Neuro-Oncology from the American Academy of Neurology, the Boyer Clinical Research Award from Memorial Sloan-Kettering Cancer Center, and the Gary Lichtenstein Humanitarian Award from Voices Against Brain Cancer.Dr. Lassman earned his BS and MS degrees in Molecular Biophysics and Biochemistry, as part of a combined four-year program at Yale University. He attained his MD from Columbia University College of Physicians and Surgeons and completed Neurology residency at the Neurological Institute of New York, at NewYork-Presbyterian/Columbia University Irving Medical Center. Dr. Lassman completed his fellowship in Neuro-Oncology at Memorial Sloan-Kettering Cancer Center, where he joined the faculty and served as fellowship director, until his return to NewYork-Presbyterian/Columbia University Irving Medical Center. Dr. Lassman is rated as an Experienced provider by MediFind in the treatment of Medulloblastoma. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Astrocytoma, Glioblastoma, Glioma, and Gliomatosis Cerebri. Dr. Lassman is board certified in Neurology. Dr. Lassman is currently accepting new patients.

Dr. Feldstein has been the director of the Division of Pediatric Neurological Surgery since his arrival in 1994. Among his interests and expertise is a national reputation in the management of Chiari Malformations and spinal dysraphism. He has an active practice in such subspecialty areas as brain and spinal cord tumors, craniofacial abnormalities, vascular malformations such as Moyamoya, AVMs and cavernous malformations. In an effort to decrease operative time and morbidity as well as hospital stay he has begun to utilize endoscopic assistance to perform common procedures through smaller incisions. This is currently seen in the management of craniosynostosis, chiari malformations and in certain forms of hydrocephalus. Dr. Feldstein’s practice is based at the Morgan Stanley Children’s Hospital of New York.His special interests include spinal dysraphism/tethered spinal cord, craniofacial surgery, brain tumors, chiari malformations, syringomyelia, vascular (Moyamoya, Aneurysm, Arteriovenous Malformations). Dr. Feldstein is rated as an Experienced provider by MediFind in the treatment of Medulloblastoma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Chiari Malformation, Chiari Malformation Type 2, Myelomeningocele, Posterior Fossa Decompression, and Rhizotomy. Dr. Feldstein is board certified in Neurological Surgery. Dr. Feldstein is currently accepting new patients.

Mary Welch, MD is an Associate Professor of Neurology at CUMC, in the Division of Neuro-Oncology. Dr. Welch graduated from Chicagos' Northwestern Feinberg School of Medicine. She completed neurology residency here at Columbia, followed by sub-specialty training in neuro-oncology at Memorial Sloan-Kettering Cancer Center. In her second year of fellowship, she earned a Comparative Effectiveness Research Award to attend Columbia's Summer Research Institute at Mailman School of Public Health.Upon completing her training, Dr. Welch worked for several years as a practicing neuro-oncologist and Assistant Professor of Neurology at Montefiore Medical Center in the Bronx. There, she served as principal investigator for numerous phase I and II clinical trials for the treatment of primary and metastatic brain cancer. She also developed a strong research interest in improving patient access to both standard and investigational therapies. In addition to seeing both inpatient and outpatient neuro-oncology patients, Dr. Welch maintains an active research program within the Division of Neuro-Oncology. Dr. Welch is rated as an Experienced provider by MediFind in the treatment of Medulloblastoma. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Astrocytoma, Glioblastoma, Glioma, and Brain Tumor. Dr. Welch is board certified in Neurology. Dr. Welch is currently accepting new patients.

Stergios Zacharoulis is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Zacharoulis is rated as an Advanced provider by MediFind in the treatment of Medulloblastoma. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Diffuse Midline Glioma H3 K27M-Mutant, Pineocytoma, Glioma, and Brain Stem Cancer. Dr. Zacharoulis is currently accepting new patients.

Dr. Justine Kahn is a Pediatric Oncologist and a clinical investigator specializing in survival outcomes, cancer care delivery, and health equity in children and adolescent/young adults (AYA) with Hodgkin lymphoma, non-Hodgkin lymphoma, acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). Dr. Kahn received her MD from the Icahn School of Medicine at Mount Sinai in New York and completed her Pediatric Residency at Mount Sinai Kravis Children’s Hospital in New York. Dr. Kahn completed her Clinical Fellowship in Pediatric Hematology/Oncology at Columbia University Medical Center. While in residency, Dr. Kahn was elected to Alpha Omega Alpha, the national medical honor society which recognizes high educational achievement. During her fellowship, Dr. Kahn served as a Postdoctoral Research Fellow in Cancer-Related Population Sciences supported by the National Cancer Institute for her work in cancer care delivery, health equity, and health outcomes research. Upon graduation from fellowship, Dr. Kahn joined the Pediatric Hematology/Oncology Division at Columbia University Medical Center as an Oncology Instructor and Attending Physician in 2016. She is currently involved in patient care, clinical trials research, and health outcomes research. In June of 2018, Dr. Kahn obtained a Master of Science in Patient Oriented Research at the Columbia Mailman School of Public Health. In July of 2018 she became an Assistant Professor of Pediatrics in the Division of Pediatric Hematology/Oncology/Stem Cell Transplantation.Dr. Kahn is actively conducting research through studies developed in the Dana-Farber Cancer Institute (DFCI) ALL Consortium, the Children's Oncology Group (COG), and at Columbia University. Columbia boasts a strong commitment to health disparities research in one of the most diverse patient populations in the United States. Dr. Kahn has chosen to focus her research efforts on underserved populations because studies suggest that poor access-to-care, low health literacy, and financial stress can all negatively impact survival in children and AYAs with cancer. Dr. Kahn is supported in part by the Lymphoma Research Foundation and recently received an institutional Career Development Award for her ongoing work on survival disparities in children and AYAs with Hodgkin lymphoma. She serves as CUMC site Principal Investigator for the DFCI ALL Consortium. Dr. Kahn is rated as an Experienced provider by MediFind in the treatment of Medulloblastoma. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Hodgkin Lymphoma, Acute Lymphoblastic Leukemia (ALL), Leukemia, Langerhans Cell Histiocytosis, and Bone Marrow Aspiration. Dr. Kahn is board certified in Pediatrics and Pediatric Hematology-Oncology. Dr. Kahn is currently accepting new patients.

James H. Garvin, MD, PhD, is a board-certified pediatric hematologist-oncologist who specializes in the care of children and adolescents with brain tumors. He is Principal Investigator at CUMC for the Head Start Program of radiation-sparing intensive chemotherapy for infants and young children with brain tumors. He was principal investigator for a Children's Oncolgy Group protocol for childhood ependymoma. He also offers novel therapies for recurrent brain tumors through our program's membership in Developmental Therapeutics Program of the COG. In addition, Dr. Garvin started the pediatric bone marrow transplant program, and continues as a member of the BMT group. He has particular interest in autologous transplant for brain tumors and allogeneic transplant for metabolic disorders and bone marrow failure syndromes, as well as supportive care for BMT patients. Dr. Garvin became interested in pediatric hematology/oncology through research during medical school in the laboratory of a pediatric hematologist. He is a member of numerous professional societies in the field. Dr. Garvin is rated as an Experienced provider by MediFind in the treatment of Medulloblastoma. His clinical expertise encompasses Brain Stem Cancer, Medulloblastoma, Glioma, Chronic Graft Versus Host Disease (cGvHD), and Bone Marrow Transplant. Dr. Garvin is board certified in Pediatrics and Pediatric Hematology-Oncology. Dr. Garvin is currently accepting new patients.

Jovana Pavisic is a Pediatrics provider practicing medicine in New York, New York. Dr. Pavisic is rated as an Experienced provider by MediFind in the treatment of Medulloblastoma. Her clinical expertise encompasses Diffuse Midline Glioma H3 K27M-Mutant, Glioma, Hepatoblastoma, and Acute Lymphoblastic Leukemia (ALL). Dr. Pavisic is board certified in Pediatrics and Pediatric Hematology-Oncology.